A potential role of IL-15 in shaping human g1 ILC phenotype and their anti-tumor functions is advocated by the increased expression of IL-15 in chRCC compared to ccRCC, and the positive correlation between IL-15 levels and ILC1 signature enrichment within the chRCC patient cohort [70]. This evidence concerns the gene IL15 and nonpapillary renal cell carcinoma.